CORCEPT THERAPEUTICS INC - 8-K Filing
On May 19, 2026, Corcept Therapeutics learned that the U.S. Department of Justice declined to intervene in a civil qui tam action filed against it by former employee Stephen Elliott in February 2017 (Case No. 17-CV-1303). The DOJ had previously issued a subpoena in November 2021 related to Korlym® sales and promotions, which the company fully responded to. On June 2, 2026, Elliott served an amended complaint; Corcept intends to defend against all claims. (Items: 8.01 Other Events)
Tickers: $CORT